Fortress Biotech, Inc. Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period
New shares the company issued (share-based compensation, option exercises, employee stock purchase plans, new issues, acquisitions), as filed in its 10-Q and 10-K XBRL statement of shareholders' equity. This is the dilution side; Issuer Repurchases is the other side.
- Fortress Biotech, Inc. share-based compensation arrangement by share-based payment award, options, exercises in period for the quarter ending 2019-03-31 was 0.00 shares.
- Fortress Biotech, Inc. share-based compensation arrangement by share-based payment award, options, exercises in period for the quarter ending 2018-09-30 was 0.00 shares.
- Fortress Biotech, Inc. share-based compensation arrangement by share-based payment award, options, exercises in period for the quarter ending 2018-06-30 was 0.00 shares.
- Fortress Biotech, Inc. share-based compensation arrangement by share-based payment award, options, exercises in period for the quarter ending 2018-03-31 was 0.00 shares.
- Fortress Biotech, Inc. share-based compensation arrangement by share-based payment award, options, exercises in period for fiscal 2025 was 0.00 shares.
- Fortress Biotech, Inc. share-based compensation arrangement by share-based payment award, options, exercises in period for fiscal 2024 was 0.00 shares.
- Fortress Biotech, Inc. share-based compensation arrangement by share-based payment award, options, exercises in period for fiscal 2023 was 0.00 shares.
- Fortress Biotech, Inc. share-based compensation arrangement by share-based payment award, options, exercises in period for fiscal 2022 was 0.00 shares.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period 3 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period 12 month |
|---|---|---|
| 2025-12-31 | 0.00 shares 10-K · filed 2026-03-31 | |
| 2024-12-31 | 0.00 shares 10-K · filed 2026-03-31 | |
| 2023-12-31 | 0.00 shares 10-K · filed 2025-03-31 | |
| 2022-12-31 | 0.00 shares 10-K · filed 2024-03-28 | |
| 2021-12-31 | 0.00 shares 10-K · filed 2023-03-31 | |
| 2020-12-31 | 100.00K shares 10-K · filed 2022-03-28 | |
| 2019-03-31 | 0.00 shares 10-Q · filed 2019-05-10 | |
| 2018-09-30 | 0.00 shares derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-09 | |
| 2018-06-30 | 0.00 shares derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-09 | |
| 2018-03-31 | 0.00 shares 10-Q · filed 2018-05-10 | |
| 2017-09-30 | 0.00 shares derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-09 | |
| 2016-12-31 | 20.00K shares 10-K · filed 2018-03-16 | |
| 2015-12-31 | 0.00 shares derived: 10-K 12 month − 10-Q 9 month · filed 2016-03-15 | 100.00K shares 10-K · filed 2016-03-15 |
| 2015-09-30 | -99.90M shares derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-09 | -322.99M shares derived: sum of 4 quarters · filed 2015-11-09 |
| 2015-06-30 | 0.00 shares derived: 10-Q 6 month − 10-Q 3 month · filed 2015-08-10 | -223.09M shares derived: sum of 4 quarters · filed 2015-08-10 |
| 2015-03-31 | 100.00M shares 10-Q · filed 2015-05-11 | 357.07M shares derived: sum of 4 quarters · filed 2015-05-11 |
| 2014-12-31 | -323.09M shares derived: 10-K 12 month − 10-Q 9 month · filed 2015-03-16 | 323.41K shares 10-K · filed 2015-03-16 |
| 2014-09-30 | 0.00 shares derived: 10-Q 9 month − 10-Q 6 month · filed 2014-11-06 | 322.46M shares derived: sum of 4 quarters · filed 2014-11-06 |
| 2014-06-30 | 580.16M shares derived: 10-Q 6 month − 10-Q 3 month · filed 2014-08-11 | 322.62M shares derived: sum of 4 quarters · filed 2014-08-11 |
| 2014-03-31 | -256.75M shares 10-Q · filed 2014-05-12 | -257.49M shares derived: sum of 4 quarters · filed 2014-05-12 |
| 2013-12-31 | -950.31K shares derived: 10-K 12 month − 10-Q 9 month · filed 2014-03-14 | -550.16K shares 10-K · filed 2014-03-14 |
| 2013-09-30 | 155.00K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2013-11-01 | |
| 2013-06-30 | 51.67K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2013-08-05 | |
| 2013-03-31 | 193.49K shares 10-Q · filed 2013-05-09 | |
| 2011-12-31 | 138.08K shares 10-K · filed 2013-03-18 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ALX ONCOLOGY HOLDINGS INC (ALXO) | United States | $0.187B | -3.52 |
| PepGen Inc. (PEPG) | United States | $0.186B | -1.73 |
| AN2 Therapeutics, Inc. (ANTX) | United States | $0.185B | -4.84 |
| Organogenesis Holdings Inc. (ORGO) | United States | $0.182B | -3.70 |
| Zentalis Pharmaceuticals, Inc. (ZNTL) | United States | $0.196B | -2.48 |
| ORAMED PHARMACEUTICALS INC. (ORMP) | $0.199B | 1.13 | |
| Nkarta, Inc. (NKTX) | United States | $0.205B | -1.73 |
| Tonix Pharmaceuticals Holding Corp. (TNXP) | United States | $0.166B | -1.34 |
| Minerva Neurosciences, Inc. (NERV) | United States | $0.165B | -0.66 |
| ADC Therapeutics SA (ADCT) | $0.163B | -1.39 |